Literature DB >> 8397259

IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.

D E Hatzigeorgiou1, S He, J Sobel, K H Grabstein, A Hafner, J L Ho.   

Abstract

IL-6 is a cytokine synthesized by T cells and macrophages (M phi). It has pleiotropic effects on diverse cell types and is recognized for its "pro-inflammatory" properties. In mice, IL-4, IL-5, IL-6, and IL-10 are produced by Th-2 cells. Because IL-10 suppresses Th-1 clones, and IL-4 broadly deactivates M phi, experiments were carried out to investigate the in vitro effects of recombinant human IL-6 on cytokine activation of human M phi. Pretreatment with IL-6 induced a dose- and time-dependent suppression of IFN-gamma (1000 U/mL) and TNF-alpha (25 ng/mL) activation of M phi for the killing of L. amazonensis. At doses greater than 0.1 to 100 ng/mL, IL-6 inhibited IFN-gamma and TNF-alpha activation by 21 to 93% and 36 to 82%, respectively. IL-6 alone had no effect on M phi viability and intracellular L. amazonensis growth. Blockade of M phi activation was greatest when IL-6 was added 24 or 48 h before infection and treatment with IFN-gamma or TNF-alpha. Furthermore, mAb against IL-6 abrogated the inhibitory activity of IL-6. Similarly IL-6 pretreatment suppressed M phi activation for antileishmanial capacity by IL-3, granulocyte-monocyte-CSF (GM-CSF) and IL-1 beta. Because cytokine induction of antileishmanial activity is associated with enhancement of oxidative capacity, the effect of IL-6 on this mechanism was evaluated. Pretreatment with IL-6 down-modulated TNF-alpha (25 ng/mL) enhancement of M phi oxidative capacity in a dose- and time-dependent manner. A similar depression of oxidative capacity was observed for GM-CSF and IL-3 but not for IFN-gamma. Furthermore, NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) had no effect on IFN-gamma and TNF-alpha activation of antileishmanial activity and nitrites/nitrates were not reliably assayed from M phi culture supernatants. These findings suggest that IL-6 down-modulates cytokine activation of M phi antileishmanial capacity by inhibiting oxygen-dependent and undefined oxygen-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397259

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.

Authors:  Jan Carlo Delorenzi; Leonardo Freire-de-Lima; Cerli R Gattass; Deise de Andrade Costa; Liwen He; Martin E Kuehne; Elvira M B Saraiva
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

Authors:  I K Santos; C H Costa; H Krieger; M F Feitosa; D Zurakowski; B Fardin; R B Gomes; D L Weiner; D A Harn; R A Ezekowitz; J E Epstein
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

Authors:  A R Satoskar; M Bozza; M Rodriguez Sosa; G Lin; J R David
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence.

Authors:  D E Hatzigeorgiou; J Geng; B Zhu; Y Zhang; K Liu; W N Rom; M J Fenton; S J Turco; J L Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  A critical role for SOCS3 in innate resistance to Toxoplasma gondii.

Authors:  Ryan J Whitmarsh; Carolyn M Gray; Beth Gregg; David A Christian; Michael J May; Peter J Murray; Christopher A Hunter
Journal:  Cell Host Microbe       Date:  2011-09-15       Impact factor: 21.023

6.  Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis.

Authors:  P Theisen-Popp; R Müller-Peddinghaus
Journal:  Agents Actions       Date:  1994-08

Review 7.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

8.  Transcription factor network reconstruction using the living cell array.

Authors:  Eric Yang; Martin L Yarmush; Ioannis P Androulakis
Journal:  J Theor Biol       Date:  2008-10-22       Impact factor: 2.691

9.  Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells.

Authors:  Dirceu J Costa; Cecília Favali; Jorge Clarêncio; Lílian Afonso; Viviane Conceição; José Carlos Miranda; Richard G Titus; Jesus Valenzuela; Manoel Barral-Netto; Aldina Barral; Cláudia Ida Brodskyn
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.

Authors:  Henry W Murray
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.